Literature DB >> 3997286

Phenotypic interconversion of B16 melanoma clonal cell populations: relationship between metastasis and tumor growth rate.

C W Stackpole, D M Fornabaio, A L Alterman.   

Abstract

Three distinct dissemination-related phenotypes have been recognized in clones of the mouse B16 melanoma based on in vivo behavior: metastatic (spontaneously disseminating to the lungs from solid tumors), colonizing (capable of forming tumor colonies in the lungs following intravenous injection), and null (tumorigenic but non-metastatic and non-colonizing). From a progenitor null clone, G3, subclones that became phenotypically diversified in vitro (metastatic G3.5 and null G3.15) and in vivo (metastatic G3.12 and colonizing G3.26) were derived. During long-term culturing, G3 cells became metastatic and then lost that activity, G3.5 and G3.12 cells gradually lost metastatic activity, and G3.26 cells became slightly metastatic and non-colonizing. Subclone G3.15 became highly metastatic after a single subcutaneous (s.c.) tumor passage. In aged mice, and in young mice injected with incompletely-tumorigenic cell doses, G3 and G3.26 s.c. tumors were metastatic, but cells cultured from those tumors or metastases were non-metastatic when tested in young mice at standard highly-tumorigenic cell doses. The behavior of G3.5 and G3.12 tumors was not altered in aged mice or when tumors were initiated with small cell inocula. Analysis of growth characteristics associated with these phenotypic interconversions indicated that lung-colonizing potential was directly related to the ability of the cells to grow as multicell colonies in 0.3% agar, and that metastatic activity was expressed by tumors that grew at moderate rates. In young mice receiving standard cell doses, G3.5 and G3.12 tumors inherently grew at that rate, whereas G3 and G3.26 tumors grew more rapidly and G3.15 tumors grew more slowly. Regardless of inherent phenotype, all clones were capable of expressing metastatic activity, at least transiently, as tumor growth was altered to moderate rates. Expression of metastatic behavior might, therefore, be regulated to some extent by tumor growth characteristics.

Entities:  

Mesh:

Year:  1985        PMID: 3997286     DOI: 10.1002/ijc.2910350516

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 2.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  Swainsonine: a new antineoplastic immunomodulator.

Authors:  S Mohla; M J Humphries; S L White; K Matsumoto; S A Newton; C C Sampson; D Bowen; K Olden
Journal:  J Natl Med Assoc       Date:  1989-10       Impact factor: 1.798

4.  Growth of metastases of the mouse adenocarcinoma EO 771: an allometric relationship between growth of the primary tumors and their metastases.

Authors:  I D Bassukas; B Maurer-Schultze
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

5.  Acquisition of in vitro growth autonomy during B16 melanoma malignant progression is associated with autocrine stimulation by transferrin and fibronectin.

Authors:  C W Stackpole; S S Kalbag; L Groszek
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

6.  Failure of orally administered RA233 to influence B16 melanoma growth or metastasis.

Authors:  C W Stackpole; D M Fornabaio; A L Alterman
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

Review 7.  The natural history of a family of transplantable melanomas in hamsters.

Authors:  A Bomirski; A Słominski; J Bigda
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

8.  Differences in organization of metastatic and nonmetastatic tumors initiated by the same B16 melanoma clone in mature and young mice.

Authors:  C W Stackpole; A L Alterman; C V Angadi; Y S Kim; D M Fornabaio
Journal:  Clin Exp Metastasis       Date:  1990 May-Jun       Impact factor: 5.150

9.  NIH3T3 transfectant containing human K-ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co-culture with fibroblasts.

Authors:  Y Takiguchi; Y Takahashi; T Kuriyama; T Miyamoto
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

10.  Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis.

Authors:  C W Stackpole; A L Alterman; D M Fornabaio
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.